Display options
Cite
de Vor L, van Dijk B, van Kessel K, et al. Human monoclonal antibodies against . Elife. 2022;11doi: 10.7554/eLife.67301.
de Vor, L., van Dijk, B., van Kessel, K., Kavanaugh, J. S., de Haas, C., Aerts, P. C., Viveen, M. C., Boel, E. C., Fluit, A. C., Kwiecinski, J. M., Krijger, G. C., Ramakers, R. M., Beekman, F. J., Dadachova, E., Lam, M. G., Vogely, H. C., van der Wal, B. C., van Strijp, J. A., Horswill, A. R., Weinans, H., & Rooijakkers, S. H. (2022). Human monoclonal antibodies against . eLife, 11. https://doi.org/10.7554/eLife.67301
de Vor, Lisanne, et al. "Human monoclonal antibodies against ." eLife vol. 11 (2022). doi: https://doi.org/10.7554/eLife.67301
de Vor L, van Dijk B, van Kessel K, Kavanaugh JS, de Haas C, Aerts PC, Viveen MC, Boel EC, Fluit AC, Kwiecinski JM, Krijger GC, Ramakers RM, Beekman FJ, Dadachova E, Lam MG, Vogely HC, van der Wal BC, van Strijp JA, Horswill AR, Weinans H, Rooijakkers SH. Human monoclonal antibodies against . Elife. 2022 Jan 06;11. doi: 10.7554/eLife.67301. PMID: 34989676; PMCID: PMC8751199.
Copy Download .nbib Format: NLM
Share it on

Elife. 2022 Jan 06;11. doi: 10.7554/eLife.67301.

Human monoclonal antibodies against .

eLife

Lisanne de Vor, Bruce van Dijk, Kok van Kessel, Jeffrey S Kavanaugh, Carla de Haas, Piet C Aerts, Marco C Viveen, Edwin C Boel, Ad C Fluit, Jakub M Kwiecinski, Gerard C Krijger, Ruud M Ramakers, Freek J Beekman, Ekaterina Dadachova, Marnix Geh Lam, H Charles Vogely, Bart Ch van der Wal, Jos Ag van Strijp, Alexander R Horswill, Harrie Weinans, Suzan Hm Rooijakkers

Affiliations

  1. Department of Medical Microbiology, University Medical Centre Utrecht, Utrecht, Netherlands.
  2. Department of Orthopedics, University Medical Centre Utrecht, Utrecht, Netherlands.
  3. Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, United States.
  4. Department of Radiology and Nuclear Medicine, University Medical Centre Utrecht, Utrecht, Netherlands.
  5. MILabs B.V, Utrecht, Netherlands.
  6. Department of Translational Neuroscience, Brain Center Rudolf Magnus, University Medical Center, Utrecht, Netherlands.
  7. Department of Radiation Science and Technology, Delft University of Technology, Delft, Netherlands.
  8. College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Canada.
  9. Department of Veterans Affairs, Eastern Colorado Health Care System, Denver, United States.
  10. Department of Biomechanical engineering, TU Delft, Delft, Netherlands.

PMID: 34989676 PMCID: PMC8751199 DOI: 10.7554/eLife.67301

Abstract

Implant-associated

© 2022, de Vor et al.

Keywords: Staphylococcus aureus; biofilm; infectious disease; microbiology; monoclonal antibodies

Conflict of interest statement

Ld, Bv, Kv, JK, Cd, PA, MV, EB, AF, JK, GK, ED, ML, HV, Bv, Jv, AH, HW, SR No competing interests declared, RR Ruud M. Ramakers has stock appreciation rights at MILabs B.V, FB Freek J. Beekman is shar

References

  1. Nature. 2019 Aug;572(7767):E1-E2 - PubMed
  2. Infect Immun. 2002 Aug;70(8):4433-40 - PubMed
  3. Biomaterials. 2007 Mar;28(9):1711-20 - PubMed
  4. J Bacteriol. 2020 Mar 26;202(8): - PubMed
  5. mBio. 2014 Oct 14;5(5):e01341-14 - PubMed
  6. Int J Artif Organs. 2005 Nov;28(11):1091-100 - PubMed
  7. Genome Announc. 2017 Mar 30;5(13): - PubMed
  8. J Clin Microbiol. 2005 Apr;43(4):1973-6 - PubMed
  9. Nat Rev Microbiol. 2018 Jul;16(7):397-409 - PubMed
  10. Infect Immun. 2009 Apr;77(4):1623-35 - PubMed
  11. Trends Microbiol. 2001 Jan;9(1):34-9 - PubMed
  12. Phys Med Biol. 2016 Jun 7;61(11):4300-15 - PubMed
  13. Trends Microbiol. 2019 Apr;27(4):303-322 - PubMed
  14. N Engl J Med. 2014 Mar 27;370(13):1198-208 - PubMed
  15. Antimicrob Agents Chemother. 2016 Mar 25;60(4):2292-301 - PubMed
  16. Microbiology (Reading). 1998 Dec;144 ( Pt 12):3387-3395 - PubMed
  17. J Bacteriol. 2004 Jul;186(14):4665-84 - PubMed
  18. Mol Microbiol. 2014 Sep;93(6):1246-58 - PubMed
  19. J Orthop Res. 2015 Sep;33(9):1311-9 - PubMed
  20. J Orthop Res. 2010 Jan;28(1):55-61 - PubMed
  21. J Knee Surg. 2014 Oct;27(5):399-406 - PubMed
  22. Infect Immun. 2006 May;74(5):2742-50 - PubMed
  23. J Immunol. 2005 Sep 15;175(6):3907-19 - PubMed
  24. Microbiol Mol Biol Rev. 2020 Aug 12;84(3): - PubMed
  25. Infect Immun. 2001 Jun;69(6):4079-85 - PubMed
  26. Infect Immun. 2002 Jun;70(6):2758-62 - PubMed
  27. EBioMedicine. 2016 Nov;13:328-338 - PubMed
  28. J Mol Biol. 1993 Apr 5;230(3):812-23 - PubMed
  29. Zentralbl Bakteriol Mikrobiol Hyg A. 1984 Dec;258(4):472-9 - PubMed
  30. PLoS Pathog. 2013;9(10):e1003653 - PubMed
  31. Clin Microbiol Rev. 2015 Jul;28(3):603-61 - PubMed
  32. PLoS One. 2017 Aug 31;12(8):e0183913 - PubMed
  33. MAbs. 2014 May-Jun;6(3):689-96 - PubMed
  34. Nature. 2015 Nov 19;527(7578):323-8 - PubMed
  35. Sci Rep. 2018 Feb 2;8(1):2254 - PubMed
  36. Infect Immun. 2014 Oct;82(10):4253-64 - PubMed
  37. Infect Immun. 1993 Oct;61(10):4167-72 - PubMed
  38. Int J Antimicrob Agents. 2007 Jul;30(1):72-7 - PubMed
  39. Microbiology (Reading). 2007 Aug;153(Pt 8):2435-2446 - PubMed
  40. J Bacteriol. 2008 Jun;190(11):3835-50 - PubMed
  41. Curr Opin Struct Biol. 2020 Jun;62:48-55 - PubMed
  42. mBio. 2015 Jun 30;6(4):e00632 - PubMed
  43. Clin Infect Dis. 2006 Mar 1;42(5):647-56 - PubMed
  44. mBio. 2013 Feb 12;4(1):e00537-12 - PubMed
  45. Clin Infect Dis. 2020 Jan 1;70(1):19-25 - PubMed
  46. J Bacteriol. 1996 Jan;178(1):175-83 - PubMed
  47. Mol Immunol. 2003 Oct;40(6):307-17 - PubMed
  48. Curr Microbiol. 2015 May;70(5):698-703 - PubMed
  49. Mucosal Immunol. 2011 Nov;4(6):625-37 - PubMed
  50. J Clin Microbiol. 2007 May;45(5):1379-88 - PubMed
  51. N Engl J Med. 1998 Aug 20;339(8):520-32 - PubMed
  52. Microbiol Spectr. 2018 Aug;6(4): - PubMed
  53. Infect Immun. 2005 Aug;73(8):5229-32 - PubMed
  54. Infect Immun. 2003 Dec;71(12):6864-70 - PubMed
  55. J Endotoxin Res. 2005;11(6):348-56 - PubMed
  56. Front Cell Infect Microbiol. 2014 Dec 23;4:178 - PubMed
  57. Nat Commun. 2020 Feb 21;11(1):1007 - PubMed
  58. Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1327-32 - PubMed
  59. Infect Immun. 2002 Feb;70(2):938-44 - PubMed
  60. Emerg Infect Dis. 2015 Nov;21(11):1973-80 - PubMed
  61. Front Cell Infect Microbiol. 2015 Jan 28;5:1 - PubMed
  62. Annu Rev Microbiol. 2013;67:313-36 - PubMed
  63. J Nucl Med. 2013 Feb;54(2):306-12 - PubMed
  64. Appl Environ Microbiol. 2005 May;71(5):2663-76 - PubMed
  65. Sci Rep. 2019 Mar 1;9(1):3212 - PubMed
  66. Trends Pharmacol Sci. 2016 Mar;37(3):231-241 - PubMed
  67. FEBS Lett. 2020 Aug;594(16):2556-2569 - PubMed
  68. J Infect Dis. 2016 Jan 1;213(1):139-48 - PubMed
  69. Sci Rep. 2019 Nov 13;9(1):16663 - PubMed
  70. Science. 2001 Aug 10;293(5532):1155-9 - PubMed
  71. Sci Rep. 2015 Nov 24;5:17219 - PubMed
  72. PLoS One. 2020 May 14;15(5):e0233086 - PubMed
  73. J Infect Dis. 2008 Aug 15;198(4):561-70 - PubMed
  74. J Antibiot (Tokyo). 2012 Feb;65(2):73-7 - PubMed
  75. MAbs. 2018 Oct;10(7):979-991 - PubMed
  76. Pharmaceutics. 2019 Jul 18;11(7): - PubMed
  77. J Bacteriol. 2001 May;183(9):2888-96 - PubMed
  78. Infect Immun. 2003 Feb;71(2):882-90 - PubMed
  79. J Nucl Med. 2014 May;55(5):830-7 - PubMed
  80. Environ Microbiol. 2015 Dec;17(12):5073-88 - PubMed
  81. J Biol Chem. 2018 Apr 6;293(14):5079-5089 - PubMed
  82. PLoS One. 2010 Apr 14;5(4):e10146 - PubMed
  83. Microbiologyopen. 2015 Jun;4(3):436-51 - PubMed
  84. J Infect Dis. 2015 Dec 15;212(12):1883-93 - PubMed
  85. J Immunol Methods. 1997 Feb 14;201(1):25-34 - PubMed
  86. Pharmaceutics. 2018 Dec 05;10(4): - PubMed

Publication Types

Grant support